VIDA is transforming pulmonary care through intelligence.  Powered by a unique combination of AI and quality-controlled image analysis services, VIDA’s solution aims to provide greater precision and personalization across a range of lung diseases including cancer, emphysema, airway obstructive diseases, asthma and interstitial lung disease.  LungPrint® is part of the VIDA|vision^® Software Suite and available for clinical use in the USA, EU, Canada and Australia.  More at vidalung.ai.